Ibopamine

DB13316ExperimentalSmall molecule

Ibopamine is a sympathomimetic, indicated in the induction of mydriasis and treatment of pos-surgical ocular hypotonia. A medication used to treat low pressure in the eye after surgery or to dilate the pupils.

Mechanism: Pharmacologically active on Dopamine receptor D1, Beta-1 adrenergic receptor, and Beta-2 adrenergic receptor
Curator reviewed
Formula / weight: C₁₇H₂₅NO₄ · 307.3847 g/mol (avg)

Resolves to

Compound

UNII8ZCA2I2L11CAS66195-31-1ChEMBLCHEMBL307739ChEBI135306

Clinical / RWD

RxNorm51253ATCC01CA16ATCS01FB03

Structure

InChIKeyWDKXLLJDNUBYCY-UHFFFAOYSA-NSMILESCNCCC1=CC(OC(=O)C(C)C)=C(OC(=O)C(C)C)C=C1

Targets

P21728DRD1P08588ADRB1P07550ADRB2P14416DRD2

What you can answer from here — as of October 11, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1,247Drug interactionsStructured to mechanism, not free text

5Structured indicationsCondition, population, route and combination as fields, not prose

3ContraindicationsEach with its own population and attribute set

11Marketed productsAcross 1 country and 3 labellers

2ATC codesIncluding every combination product, plus 29 drug categories

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ibopamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In